ITCH and B-cell chronic lymphocytic leukemia: Sampath and collaborators [79] have reported that treatment of CLL primary cells with deacetylase inhibitors reactivates E2F1- and MYC-mediated transcription of miR106b, which, in turn, promotes ITCH downregulation and p73 stabilization (Fig. 4).